tradingkey.logo
tradingkey.logo
Search

Drugs Made In America Acquisition Corp

DMAAU
Add to Watchlist
10.800USD
+0.190+1.79%
Close 07/02, 13:00ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

Drugs Made In America Acquisition Corp

10.800
+0.190+1.79%

More Details of Drugs Made In America Acquisition Corp Company

Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.

Drugs Made In America Acquisition Corp Info

Ticker SymbolDMAAU
Company nameDrugs Made In America Acquisition Corp
IPO dateJan 28, 2025
CEOStockwell (Lynn)
Number of employees- -
Security typeUnit
Fiscal year-end- -
Address1 East Broward Boulevard
CityFT LAUDERDALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33301
Phone19548703099
Website
Ticker SymbolDMAAU
IPO dateJan 28, 2025
CEOStockwell (Lynn)

Company Executives of Drugs Made In America Acquisition Corp

Name
Name/Position
Position
Shareholding
Change
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--

FAQs

Who are the top five shareholders of Drugs Made In America Acquisition Corp?

The top five shareholders of Drugs Made In America Acquisition Corp are: Ms. Lynn Stockwell

How many institutions hold shares of Drugs Made In America Acquisition Corp (DMAAU)?

As of 2026Q1, 21 institutions hold shares of Drugs Made In America Acquisition Corp, with a combined market value of approximately 472.47K, accounting for 2.02% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -2919166.00.